Fibrosis quantification in Hypertensive Heart Disease with LVH and Non-LVH: Findings from T1 mapping and Contrast-free Cardiac Diffusion-weighted imaging
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-00627-5
Abstract: This study assessed the extent of fibrosis and the relationship between the ADC value and systolic strain in hypertensive patients with left ventricular hypertrophy (HTN LVH) and hypertensive patients without LVH (HTN non-LVH) using cardiac… read more here.
Keywords: htn lvh; htn; htn non; non lvh ... See more keywords
In many patients with hypertensive left ventricular hypertrophy, a beta-blocker is needed because of the prevalent myocardial ischemia.
Sign Up to like & getrecommendations! Published in 2023 at "Current vascular pharmacology"
DOI: 10.2174/1570161121666230201141215
Abstract: BACKGROUND arterial hypertension (HTN) is a key risk factor for left ventricular hypertrophy (LVH) and a cause of ischemic heart disease (IHD). The association of myocardial ischemia and HTN LVH is strong because myocardial ischemia… read more here.
Keywords: patients htn; ischemia; myocardial ischemia; left ventricular ... See more keywords
A meta-analysis of the diagnostic value of microRNA for hypertensive left ventricular hypertrophy
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.994826
Abstract: In this study, the diagnostic value of microRNAs (miRNAs) for hypertension (HTN) with left ventricular hypertrophy (LVH) were evaluated by meta-analysis. A correlation study of the diagnostic value of miRNAs in HTN with LVH was… read more here.
Keywords: htn lvh; analysis; left ventricular; diagnostic value ... See more keywords